Katrina Snow/ LinkedIn
Sep 17, 2026, 20:17
Katrina Snow: Whole Blood or Component Therapy – Which Would You Choose?
Katrina Snow, Transfusion Safety Officer at North York General Hospital, shared a post on LinkedIn:
“Picture this scenario: you have experienced a traumatic bleed and you need blood immediately. The clinical team caring for you has access to whole blood (LTOWB) and component therapy.
What do you want them to choose for you (whole blood vs. component therapy), and why?
For me (an RhD-negative female of childbearing potential) I’d be hoping they choose component therapy.”
Find more posts featuring Katrina Snow on Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke